Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose
Running, not enrolling
Conditions studied: Caregiver, Patient
In brief
This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.
Key facts
- Study ID
- NCT04129138
- Run by
- M.D. Anderson Cancer Center
- People needed
- 182
- Starts
- 2020-07-18
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2026-04-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients must have been prescribed intranasal naloxone in the past 1 year
- Patients and caregivers must be able to understand, read, write, and speak English
- Patients must have no clinical evidence of cognitive impairment, as determined by the palliative care provider (Memorial Delirium Assessment Scale score of >= 7)
- Patients must sign an informed consent
- Caregivers may sign an informed consent if available during the visit
- Caregivers may verbally consent over the phone if not present during the visit
- Caregiver must be a friend, significant other or family member
- Caregivers must have no evidence of cognitive impairment, as determined based on orientation questions pertaining to the date, day of the week, time, and place
You may not qualify if…
- PATIENT: Emotional or psychosocial distress as identified by the patient's palliative care
- PATIENT: Participants with Edmonton Symptom Assessment System (ESAS) anxiety score of > 6
Where it is running
- M D Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.